查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511941

生物可吸收血管支架市场规模、份额、趋势分析报告：按应用、最终用途、地区和细分市场预测，2024-2030 年

Bioresorbable Vascular Scaffold Market Size, Share & Trends Analysis Report By Application (Peripheral Artery, Coronary Artery), By End-use (Hospitals, Ambulatory Care Centers, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10个工作天内

价格

生物可吸收血管支架市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球生物可吸收血管支架市场规模将达到7.1509亿美元，2024年至2030年复合年增长率为8.7%。

由于心血管疾病的盛行率不断增加以及对有效和微创治疗的需求，该市场正在经历显着增长。根据 2024 年心臟病和中风统计数据更新情况表，心血管疾病 (CVD) 仍然是美国的重大公共卫生问题，2021 年将有 931,578 人死于心血管疾病。 2021 年，心臟病和中风的影响将是惊人的，夺走的生命比癌症和慢性呼吸道疾病的总合多。

CVD 的盛行率高得惊人，2017 年至 2020 年间，有 1.279 亿美国成年人 (48.6%) 患有某种形式的 CVD。 CVD 的经济负担也很巨大，2019 年至 2020 年间，直接和间接成本总额总合为 4,223 亿美元，其中直接成本为 2,543 亿美元，生产力损失和死亡率高达 1,680 亿美元。这些统计数据突显，迫切需要继续进行研究、预防和治疗工作，以解决美国日益增长的心血管疾病负担。

除了心血管疾病的日益普及之外，生物可吸收血管支架（BVS）的技术进步和强大的产品平臺预计将在预测期内推动市场成长。例如，製造商雅培宣布，2024 年 4 月，美国食品药物管理局核准依Everolimus洗脱生物可吸收支架（Esprit BTK）用于膝下（BTK）腘窝下疾病患者。这项核准凸显了 BVS 市场的持续发展和创新，为心血管疾病患者提供了新的治疗选择。

此外，具有增强机械性能的下一代生物可吸收血管支架（BRS）的发展是推动全球市场扩张的关键催化剂。先前的BRS面临支柱厚度和横断面高度等挑战，限制了其广泛使用。然而，现代 BRS 采用具有卓越机械性能的可吸收材料，可以製造更薄的支柱并减少交叉轮廓，从而改善输送、兼容性以及与复杂病变和小血管的兼容性。

这些进步改善了临床结果，例如加速血管癒合、降低血管再阻塞率以及降低支架血栓症等不利事件的风险，从而导致全球范围内越来越多地采用 BRS。对微创治疗的日益偏好、人口老化以及全球心血管疾病盛行率的上升表明全球范围内市场的发展前景光明。

生物可吸收血管支架市场报告亮点

  • 2023年，冠脉业务占收益占有率为84.59%。这是由于冠状动脉疾病的高盛行率以及对微创治疗的需求不断增加。此外，生物可吸收支架技术的进步正在改善设备性能和患者治疗结果，进一步推动该领域的成长。
  • 2023年，医院业务收益占有率最大，超过74.21%。这是由于医院进行了大量的心血管手术并且拥有先进的医疗设备。例如，根据美国心臟学会的数据，2023 年美国医院进行了超过 90 万例冠状动脉介入治疗。如此大量的手术，再加上生物可吸收血管支架的优点，例如减少长期併发症和改善患者预后，有助于在医院领域占据最高份额。
  • 由于患有心血管疾病的患者数量众多、医疗基础设施完善以及先进医疗技术的采用率较高，北美在 2023 年占据市场占有率领先地位。此外，该地区是多家市场主要企业的所在地，包括雅培（Abbott）、波士顿科学公司（Boston Scientific Corporation）和美Medtronic） ，他们不断投资于研发活动，以开发创新产品并扩大其市场份额。
  • 市场参与者正在实施各种策略性倡议，以扩大其产品在不同地区的覆盖范围和可用性。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章生物可吸收血管支架市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 生物可吸收血管支架市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章生物可吸收血管支架市场：应用估算与趋势分析

  • 生物可吸收血管支架市场：应用仪表板
  • 生物可吸收血管支架市场：应用变化分析
  • 2018-2030年生物可吸收血管支架市场规模、预测与趋势分析（依应用）
  • 週边动脉
  • 冠状动脉

第五章全球生物可吸收血管支架市场：最终用途估计与趋势分析

  • 生物可吸收血管支架市场：最终用途仪表板
  • 生物可吸收血管支架市场：最终用途变化分析
  • 2018-2030 年生物可吸收血管支架市场规模、预测与趋势分析（依最终用途）
  • 医院
  • 门诊护理中心 (ACS)
  • 专科诊所

第六章生物可吸收血管支架市场：按国家、产品和最终用途进行的区域估计和趋势分析

  • 生物可吸收血管支架市场：区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第七章 竞争格局

  • 主要製造商的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Abbott
    • Kyoto Medical
    • Biotronik
    • Elixir Medical
    • CR Bard, Inc.,
    • Teleflex Incorporated
    • B. Braun Melsungen AG
    • Medtronic Plc
    • Argon Medical Devices, Inc
Product Code: GVR-4-68040-313-5

Bioresorbable Vascular Scaffold Market Growth & Trends:

The global bioresorbable vascular scaffold market size is expected to reach USD 715.09 million by 2030, expanding at a CAGR of 8.7% from 2024 to 2030, based on a new Grand View Research, Inc. report. The market is experiencing significant growth driven by the increasing prevalence of cardiovascular diseases and the need for effective, minimally invasive treatments. According to the 2024 Heart Disease and Stroke Statistics Update Fact Sheet, cardiovascular disease (CVD) remains a significant public health concern in the U.S., with 931,578 deaths attributed to it as the underlying cause in 2021. The impact of heart disease and stroke is staggering, as they claimed more lives in 2021 than all forms of cancer and chronic lower respiratory disease combined.

The prevalence of CVD is alarmingly high, with 127.9 million US adults (48.6%) having some form of the disease between 2017 and 2020. The economic burden of CVD is also substantial, with direct and indirect costs totaling USD 422.3 billion between 2019 and 2020, including USD 254.3 billion in direct costs and USD 168.0 billion in lost productivity and mortality. These statistics underscore the urgent need for continued research, prevention, and treatment efforts to address the growing burden of cardiovascular disease in the U.S.

In addition to the increasing prevalence of CVD, technological advancements in the bioresorbable vascular scaffold (BVS) and a robust product pipeline are other factors expected to drive the growth of the market during the forecast period. For instance, in April 2024, the US Food and Drug Administration approved an everolimus-eluting bioresorbable scaffold (Esprit BTK) for patients with below-the-knee (BTK) infrapopliteal disease, according to an announcement from manufacturer Abbott. This approval highlights the ongoing development and innovation in the BVS market, providing new treatment options for patients with cardiovascular conditions.

Moreover, the evolution of next-generation bioresorbable vascular scaffolds (BRSs) with enhanced mechanical properties is a significant catalyst driving the global market's expansion. Previous versions of BRSs encountered challenges such as thicker struts and higher crossing profiles, limiting their widespread application. However, the latest BRSs utilize absorbable materials with superior mechanical attributes, enabling the production of thinner struts and reduced crossing profiles, improving deliverability, conformability, and flexibility for complex lesions and smaller vessels.

These advancements have resulted in improved clinical outcomes, including enhanced vessel healing, reduced restenosis rates, and decreased risks of adverse events like stent thrombosis, fostering increased adoption of BRSs worldwide. The growing preference for minimally invasive procedures, an aging population, and the escalating prevalence of cardiovascular diseases globally indicate a promising trajectory for the market on a global scale.

Bioresorbable Vascular Scaffold Market Report Highlights:

  • The coronary artery segment accounted for a revenue share of 84.59% in 2023. This is due to the high prevalence of coronary artery diseases and the increasing demand for minimally invasive treatments. Additionally, the advancements in bioresorbable scaffold technology have led to improved device performance and patient outcomes, further driving the growth of this segment.
  • The hospitals segment held the largest revenue share of over 74.21% in 2023. This is due to the high volume of cardiovascular procedures performed in hospitals and the availability of advanced medical facilities. Additionally, hospitals often serve as referral centers for complex cases, further driving the demand for bioresorbable vascular scaffolds.For instance, in 2023, hospitals in the U.S. performed over 900,000 coronary interventions, according to the American College of Cardiology. This high procedure volume, coupled with the benefits of bioresorbable vascular scaffolds, such as reduced long-term complications and improved patient outcomes, contributes to the hospital segment's leading market share.
  • In 2023, North America led the market share, due to the presence of a large patient pool suffering from cardiovascular diseases, a well-established healthcare infrastructure, and a high adoption rate of advanced medical technologies. Additionally, the region is home to several key players in the market, such as Abbott, Boston Scientific Corporation, and Medtronic, which are continuously investing in R&D activities to develop innovative products and expand their market presence.
  • Market players are implementing various strategic initiatives to enhance product reach and availability across different geographic regions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application Type
    • 1.2.2. End-use channel
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application Segment
    • 2.2.2. End-use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Bioresorbable Vascular Scaffold Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Bioresorbable Vascular Scaffold Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Bioresorbable Vascular Scaffold Market: Application Estimates & Trend Analysis

  • 4.1. Bioresorbable Vascular Scaffold Market: Application Dashboard
  • 4.2. Bioresorbable Vascular Scaffold Market: Application Movement Analysis
  • 4.3. Bioresorbable Vascular Scaffold Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Peripheral Artery
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Coronary Artery
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Global Bioresorbable Vascular Scaffold Market: End-use Estimates & Trend Analysis

  • 5.1. Bioresorbable Vascular Scaffold Market: End-use Dashboard
  • 5.2. Bioresorbable Vascular Scaffold Market: End-use Movement Analysis
  • 5.3. Bioresorbable Vascular Scaffold Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Ambulatory Care Centers (ACS)
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Specialty Clinics
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Bioresorbable Vascular Scaffold Market: Regional Estimates & Trend Analysis by Country, Product, and End-use

  • 6.1. Bioresorbable Vascular Scaffold Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Abbott
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Application benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Kyoto Medical
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Application benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Biotronik
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Application benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Elixir Medical
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Application benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. C. R. Bard, Inc.,
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Application benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Teleflex Incorporated
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Application benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. B. Braun Melsungen AG
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Application benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Medtronic Plc
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Application benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Argon Medical Devices, Inc
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Application benchmarking
      • 7.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America bioresorbable vascular scaffold market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 7 North America bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Mexico bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 13 Mexico bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Europe bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 16 Europe bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 18 UK bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany bioresorbable vascular scaffold market, by product type, 2018 - 2030 (USD Million)
  • Table 20 Germany bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 France bioresorbable vascular scaffold market, by product type, 2018 - 2030 (USD Million)
  • Table 22 France bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Italy bioresorbable vascular scaffold market, by product type, 2018 - 2030 (USD Million)
  • Table 24 Italy bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Spain bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 26 Spain bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Norway bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 28 Norway bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Sweden bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 30 Sweden bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 32 Denmark bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Japan bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 37 Japan bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 China bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 39 China bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 India bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 41 India bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Australia bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 43 Australia bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 South Korea bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 45 South Korea bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Thailand bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 47 Thailand bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Latin America bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 50 Latin America bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Brazil bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 52 Brazil bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 54 Argentina bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Africa bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 59 South Africa bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 UAE bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 63 UAE bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
  • Table 65 Kuwait bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modelling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Bioresorbable vascular scaffold market segmentation
  • Fig. 9 Penetration & growth prospect mapping
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Bioresorbable vascular scaffold market application market share analysis, 2023 & 2030
  • Fig. 14 Bioresorbable vascular scaffold market application market: Application Segment dashboard
  • Fig. 15 Peripheral artery market, 2018 - 2030 (USD Million)
  • Fig. 16 Coronary artery market, 2018 - 2030 (USD Million)
  • Fig. 17 Bioresorbable vascular scaffold market by end-use market share analysis, 2023 & 2030
  • Fig. 18 Bioresorbable vascular scaffold market by end-use market: Segment dashboard
  • Fig. 19 Hospitals, 2018 - 2030 (USD Million)
  • Fig. 20 Ambulatory Care Centers, 2018 - 2030 (USD Million)
  • Fig. 21 Speciality Clinics, 2018 - 2030 (USD Million)
  • Fig. 22 Bioresorbable vascular scaffold market by regional market share analysis, 2023 & 2030
  • Fig. 23 Bioresorbable vascular scaffold market: Regional dashboard
  • Fig. 24 Regional marketplace: Key takeaways
  • Fig. 25 North America bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 30 UK bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 31 France bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 32 Germany bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 36 Norway bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 37 Sweden bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 40 China bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 41 India bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 48 MEA bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 49 Saudi Arabia bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 51 UAE bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
  • Fig. 53 Company market position analysis